Marfan Syndrome Management Market is projected to grow from USD 1.30 billion in 2025 to USD 2.94 billion by 2036, at a CAGR of 7.7%. Heart Treatments will dominate with a 30.2% treatment share, while Hospitals Pharmacies will dominate with a 50.1% distribution channel share.